AU4480997A - Screening methods for compounds useful in the treatment of schizophrenia - Google Patents

Screening methods for compounds useful in the treatment of schizophrenia

Info

Publication number
AU4480997A
AU4480997A AU44809/97A AU4480997A AU4480997A AU 4480997 A AU4480997 A AU 4480997A AU 44809/97 A AU44809/97 A AU 44809/97A AU 4480997 A AU4480997 A AU 4480997A AU 4480997 A AU4480997 A AU 4480997A
Authority
AU
Australia
Prior art keywords
schizophrenia
treatment
compounds useful
screening methods
screening
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU44809/97A
Inventor
Pullanipally Shashidharan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Icahn School of Medicine at Mount Sinai
Original Assignee
Mount Sinai School of Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mount Sinai School of Medicine filed Critical Mount Sinai School of Medicine
Publication of AU4480997A publication Critical patent/AU4480997A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/30—Psychoses; Psychiatry
    • G01N2800/302—Schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Physiology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU44809/97A 1996-09-13 1997-09-15 Screening methods for compounds useful in the treatment of schizophrenia Abandoned AU4480997A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US2525596P 1996-09-13 1996-09-13
US60025255 1996-09-13
US92831697A 1997-09-12 1997-09-12
US08928316 1997-09-12
PCT/US1997/016219 WO1998011222A1 (en) 1996-09-13 1997-09-15 Screening methods for compounds useful in the treatment of schizophrenia

Publications (1)

Publication Number Publication Date
AU4480997A true AU4480997A (en) 1998-04-02

Family

ID=26699504

Family Applications (1)

Application Number Title Priority Date Filing Date
AU44809/97A Abandoned AU4480997A (en) 1996-09-13 1997-09-15 Screening methods for compounds useful in the treatment of schizophrenia

Country Status (2)

Country Link
AU (1) AU4480997A (en)
WO (1) WO1998011222A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6476208B1 (en) 1998-10-13 2002-11-05 Genset Schizophrenia associated genes, proteins and biallelic markers
US20020081584A1 (en) * 1998-10-13 2002-06-27 Marta Blumenfeld Genes, proteins and biallelic markers related to central nervous system disease
US7067627B2 (en) 1999-03-30 2006-06-27 Serono Genetics Institute S.A. Schizophrenia associated genes, proteins and biallelic markers
US6555316B1 (en) 1999-10-12 2003-04-29 Genset S.A. Schizophrenia associated gene, proteins and biallelic markers
WO2001040493A2 (en) * 1999-11-30 2001-06-07 Genset Schizophrenia associated gene, proteins and biallelic markers
WO2001062785A2 (en) * 2000-02-24 2001-08-30 Oxford Glycosciences (Uk) Ltd. Protein and gene and their use for diagnosis and treatment of schizophrenia
WO2002008384A2 (en) * 2000-07-25 2002-01-31 The Regents Of The University Of California Novel glutamate transporters
GB0708960D0 (en) * 2007-05-09 2007-06-20 Sinclair Pharmaceuticals Ltd Method

Also Published As

Publication number Publication date
WO1998011222A1 (en) 1998-03-19

Similar Documents

Publication Publication Date Title
AU4838097A (en) Apparatus for the treatment of specimens
AU2326297A (en) Method for treating liquid materials
AU3813397A (en) Apparatus for treating chondromalicia
AU4261697A (en) Compounds and methods
AU3869895A (en) Azetidinone derivatives for the treatment of atherosclerosis
AUPP794698A0 (en) Waste treatment apparatus
AU3011397A (en) Water-stabilized organosilane compounds and methods for using the same
AU665318B2 (en) Process for obtaining diatomite-based filtering agents and corresponding filtering agents
AU2698697A (en) Azetidinone derivatives for the treatment of atherosclerosis
AU5813199A (en) Workholding apparatus
AU3444899A (en) Method for the rapid determination of bacteria
AU1697197A (en) Immunoconjugate for the treatment of aids
AU3187595A (en) Compounds for the treatment of restenosis
AU4480997A (en) Screening methods for compounds useful in the treatment of schizophrenia
AU4393497A (en) Method for the sterilization of biological materials
AU7107998A (en) Method for treating schizophrenia
AU2173597A (en) Process for the preparation of tenidap
HUP9903852A3 (en) Process for the preparation of contrast agents
AU2283497A (en) Methods for increasing the maturation of cells
AU2725395A (en) Waste treatment apparatus
AU5035198A (en) Novel beta-lactam compounds and process for preparing the same
AU3783097A (en) Process for the preparation of hexanitrohexaazaisowurtzitanes
AU5855899A (en) Method for identifying substances for the treatment of c-jun-mediated disorders
AU9240898A (en) Process for the modification of toxic and/or off-flavoured compounds
AU3250495A (en) Weir